Don't Race Out To Buy Ingersoll-Rand (India) Limited (NSE:INGERRAND) Just Because It's Going Ex-Dividend
NiveshIQ
NSE: INGERRAND
Ingersoll Rand (India) Ltd.
₹4,277.70▼ ₹7.30 (-0.17%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on INGERRAND. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Ingersoll Rand (India) Ltd.
Ingersoll-Rand (India) Limited is a leading manufacturer of industrial air compressors and related services in India, serving various sectors including aerospace, chemical, and oil and gas. The company offers a diverse portfolio of products under multiple brands, including NASH, CompAir, and Gardner Denver. Its key revenue drivers include sales of heatless desiccant dryers, heat of compression dryers, and high pressure air compressors. Ingersoll-Rand (India) Limited has a strong competitive position in the Indian market, driven by its extensive product offerings and established distribution network. The company's recent financial performance is marked by revenue of ₹1392 Cr and net income of ₹256 Cr. With a strong growth outlook, analysts have a 'Buy' rating and a target price of ₹4934. Th
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,180 Cr +4.30% | ₹1,318 Cr +11.70% | ₹1,392 Cr +5.60% |
| EBITDA Margin | 26.94% | 28.74% | 26.70% |
| Net Profit | ₹222.39 Cr +21.80% | ₹267.52 Cr +20.30% | ₹256.03 Cr -4.30% |
| EPS | ₹70.45 | ₹84.74 | ₹81.10 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
🔒
Sign in to see AI summaries
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹379 Cr, PAT ₹70 Cr, EPS ₹22.32. Growth context: revenue QoQ +26.5%, PAT QoQ +8.0%.
Key drivers for the next 2–4 quarters will be order inflow, execution conversion, capacity utilisation, project pipeline...
The company's FY26 performance was marked by revenue of ₹1, 392 Cr and PAT of ₹256 Cr, with EBITDA margin at 26.7% and E...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for INGERRAND
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track INGERRAND alongside your other holdings
Unlock full INGERRAND research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Ingersoll Rand (India) Ltd.?
NiveshIQ detects active intelligence signals for Ingersoll Rand (India) Ltd. (INGERRAND) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Ingersoll Rand (India) Ltd.?
Ingersoll Rand (India) Ltd. is listed on NSE/BSE with a market capitalisation of ₹1,350,384.4L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.